Rapid recruitment of temporally distinct vascular gene sets by estrogen.
Cardiovascular disease is the leading cause of mortality for both men and women in developed countries. The sex steroid hormone estrogen is required for normal vascular physiology. Estrogen functions by binding to intracellular estrogen receptors (ER), ERalpha and ERbeta, ligand-activated transcription factors that are expressed in both vascular endothelial and smooth muscle cells. We recently demonstrated that long-term (8 d) estrogen treatment in vivo in mice recruits distinct vascular gene sets mediated by ERalpha and ERbeta and that the promoters from these gene sets are enriched for binding sites of specific transcription factors, leading to the hypothesis that estrogen initiates a cascade of early transcriptional events that modulate gene expression in the vasculature. Here we test this hypothesis using gene expression profiling to examine initial transcriptional events (2-8 h) mediated by estrogen in blood vessels. Our data reveal that 1) estrogen regulates temporally distinct cascades of vascular gene expression, 2) initially, estrogen-mediated vascular gene repression predominates, 3) the earliest estrogen-recruited gene program is enriched in vascular transcription factors that can interact with binding sites present in estrogen-regulated vascular genes recruited subsequently, and 4) estrogen-regulated genes recruited next have specific functions, including lipid metabolism and cellular growth and proliferation that are potentially important for estrogen's known vascular functions. In summary, estrogen directly and rapidly recruits specific transcriptional factors that then propagate distinct cascades of gene expression. These data define the temporal recruitment of specific vascular genes by estrogen and enable further analysis of the mechanisms by which estrogen directly regulates vascular function.
Schnoes
Katrin K
KK
Molecular Cardiology Research Institute, Tufts Medical Center, 800 Washington Street, Box 080, Boston, Massachusetts 02111, USA.
Jaffe
Iris Z
IZ
Iyer
Lakshmanan
L
Dabreo
Alexandra
A
Aronovitz
Mark
M
Newfell
Brenna
B
Hansen
Ulla
U
Rosano
Giuseppe
G
Mendelsohn
Michael E
ME
D000818:Animals; D001011:Aorta / Q000187:drug effects* / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000209:etiology / Q000235:genetics; D004958:Estradiol / Q000494:pharmacology*; D047628:Estrogen Receptor alpha / Q000172:deficiency / Q000235:genetics*; D047629:Estrogen Receptor beta / Q000172:deficiency / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007700:Kinetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008954:Models, Biological; D005810:Multigene Family / Q000187:drug effects; D012727:Sex Characteristics; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D015533:Transcriptional Activation / Q000187:drug effects
D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D014157:Transcription Factors; D004958:Estradiol
Circ Res. 2001 Jun 8;88(11):1142-50
11397780
Cancer Res. 2000 Nov 15;60(22):6367-75
11103799
Am J Cardiol. 2002 Jul 3;90(1A):3F-6F
12106632
Mol Cell Endocrinol. 2004 Apr 30;219(1-2):17-26
15149723
Genome Biol. 2004;5(10):R80
15461798
Curr Opin Genet Dev. 2001 Oct;11(5):497-504
11532390
Best Pract Res Clin Obstet Gynaecol. 2002 Jun;16(3):329-55
12099666
JAMA. 1995 Jan 18;273(3):199-208
7807658
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Circ Res. 2000 Nov 24;87(11):956-60
11090536
N Engl J Med. 2007 Jun 21;356(25):2639-41
17582075
Mol Endocrinol. 2005 Apr;19(4):833-42
15695368
Mol Cell Biol. 2004 May;24(9):3757-68
15082771
Cardiovasc Drugs Ther. 2007 Aug;21(4):297-309
17605096
Am J Cardiol. 2002 Jun 20;89(12A):12E-17E; discussion 17E-18E
12084397
Cell. 1998 Nov 13;95(4):507-19
9827803
Circulation. 1995 May 1;91(9):2488-96
7729036
Nat Genet. 2006 Nov;38(11):1289-97
17013392
Development. 1998 Nov;125(22):4565-74
9778514
Bioinformatics. 2005 Sep 15;21(18):3683-5
16076888
Hum Mol Genet. 2004 Dec 15;13(24):3181-8
15496429
Circ Res. 2004 Oct 15;95(8):764-72
15486323
JAMA. 2007 Apr 4;297(13):1465-77
17405972
Am J Cardiol. 2002 Jun 15;89(12):1354-9
12062727
J Appl Physiol (1985). 2001 Jan;90(1):358-68
11133929
Biotechniques. 2003 Feb;34(2):374-8
12613259
J Clin Invest. 2001 Feb;107(3):333-40
11160157
J Clin Invest. 1999 May;103(9):1227-30
10225964
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6275-80
16606849
Curr Opin Lipidol. 2004 Aug;15(4):459-67
15243220
EMBO J. 1999 Aug 2;18(15):4270-9
10428965
J Clin Invest. 1995 Nov;96(5):2482-8
7593638
Mol Cell Biol. 2003 Nov;23(22):7947-56
14585956
Science. 2004 Feb 27;303(5662):1378-81
14988562
Genes Dev. 2002 Jan 15;16(2):245-56
11799067
Arterioscler Thromb Vasc Biol. 2007 Aug;27(8):1694-705
17541024
J Biol Chem. 2003 Apr 25;278(17):15297-303
12586839
Cell. 2005 Jul 15;122(1):33-43
16009131
Circ Res. 2002 May 31;90(10):1087-92
12039798
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17126-31
15569929
J Mol Endocrinol. 2006 Feb;36(1):81-9
16461929
Science. 2003 Nov 28;302(5650):1578-81
14645853
Am J Physiol. 1997 Apr;272(4 Pt 2):H1996-2003
9139988
Nature. 2000 Nov 2;408(6808):106-11
11081517
Nat Biotechnol. 2004 Jun;22(6):656-8; author reply 658
15175677
Science. 2002 Jan 18;295(5554):505-8
11799247
Circulation. 1997 Apr 1;95(7):1768-72
9107161
Circ Res. 2002 Feb 22;90(3):251-62
11861412
Mol Endocrinol. 2007 Jun;21(6):1281-96
17374850
Cardiovasc Hematol Agents Med Chem. 2007 Jan;5(1):21-7
17266545
N Engl J Med. 2007 Jun 21;356(25):2591-602
17582069
Circ Res. 2005 Apr 1;96(6):643-50
15718497
N Engl J Med. 1999 Jun 10;340(23):1801-11
10362825
J Mol Endocrinol. 2003 Jun;30(3):347-58
12790804
Science. 1994 Nov 18;266(5188):1236-40
7973707
Mol Cell Biol. 1995 Jun;15(6):3415-23
7760838
Circulation. 1995 Feb 1;91(3):755-63
7530174
Circulation. 2004 Jun 15;109(23 Suppl 1):III2-7
15198959
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15677-82
9861029
Development. 2000 Oct;127(19):4277-91
10976058
Science. 2005 Jun 10;308(5728):1583-7
15947175
BMC Bioinformatics. 2007 Jan 22;8:19
17241466